|
|
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
C23 |
Malignant neoplasm of gallbladder
|
C23 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 59.71%
|
24.45%
|
8.98%
|
2.93%
|
1.41%
|
0.93%
|
0.49%
|
0.29%
|
0.16%
|
0.16%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C23*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
6,030
|
6,031
|
|
80053
|
COMPREHEN METABOLIC PANEL |
5,983
|
5,984
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
4,757
|
4,775
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
4,044
|
4,060
|
|
86301
|
IMMUNOASSAY TUMOR CA 19-9 |
2,800
|
2,800
|
|
83735
|
ASSAY OF MAGNESIUM |
2,042
|
2,045
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
1,946
|
198,679
|
|
96413
|
CHEMO IV INFUSION 1 HR |
1,578
|
1,578
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
1,573
|
1,573
|
|
71260
|
CT THORAX DX C+ |
1,571
|
1,571
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
1,336
|
2,104
|
|
J9201
|
IN GEMCITABINE HCL NOS 200MG |
1,311
|
8,732
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
1,186
|
1,186
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
1,166
|
58,386
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
1,132
|
12,911
|
|
96417
|
CHEMO IV INFUS EACH ADDL SEQ |
956
|
1,025
|
|
36591
|
DRAW BLOOD OFF VENOUS DEVICE |
952
|
959
|
|
J7050
|
NORMAL SALINE SOLUTION INFUS |
951
|
1,216
|
|
96367
|
TX/PROPH/DG ADDL SEQ IV INF |
832
|
1,225
|
|
96361
|
HYDRATE IV INFUSION ADD-ON |
813
|
1,409
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C23 related to the following DRG Codes:
435-437
|
